These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 31071234)

  • 1. A Novel Strategy for Repairing Multiple Myeloma Bone Lesions: Lessons From Murine Models.
    Calvi LM; Hofbauer LC
    J Bone Miner Res; 2019 May; 34(5):781-782. PubMed ID: 31071234
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple myeloma.
    Smith D; Yong K
    BMJ; 2013 Jun; 346():f3863. PubMed ID: 23803862
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models.
    Paton-Hough J; Tazzyman S; Evans H; Lath D; Down JM; Green AC; Snowden JA; Chantry AD; Lawson MA
    J Bone Miner Res; 2019 May; 34(5):783-796. PubMed ID: 30320927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A murine model of human myeloma bone disease.
    Garrett IR; Dallas S; Radl J; Mundy GR
    Bone; 1997 Jun; 20(6):515-20. PubMed ID: 9177864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and management of bone lesions in multiple myeloma.
    Bataille R; Manolagas SC; Berenson JR
    Hematol Oncol Clin North Am; 1997 Apr; 11(2):349-61. PubMed ID: 9137974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of multiple myeloma with navicular bone involvement.
    Yildizhan E; Kaynar L; Tiren N; Canoz O; Eser B
    Scott Med J; 2017 Nov; 62(4):152-155. PubMed ID: 28959919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of plasmin in the pathogenesis of murine multiple myeloma.
    Eiamboonsert S; Salama Y; Watarai H; Dhahri D; Tsuda Y; Okada Y; Hattori K; Heissig B
    Biochem Biophys Res Commun; 2017 Jun; 488(2):387-392. PubMed ID: 28501622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloma and bone disease: "the dangerous tango".
    Epstein J; Walker R
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):300-6. PubMed ID: 16728940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RANKL inhibition: clinical implications for the management of patients with multiple myeloma and solid tumors with bone metastases.
    Terpos E; Efstathiou E; Christoulas D; Roussou M; Katodritou E; Dimopoulos MA
    Expert Opin Biol Ther; 2009 Apr; 9(4):465-79. PubMed ID: 19344283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines in multiple myeloma.
    Aggarwal R; Ghobrial IM; Roodman GD
    Exp Hematol; 2006 Oct; 34(10):1289-95. PubMed ID: 16982321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation.
    Binsfeld M; Beguin Y; Belle L; Otjacques E; Hannon M; Briquet A; Heusschen R; Drion P; Zilberberg J; Bogen B; Baron F; Caers J
    PLoS One; 2014; 9(11):e113764. PubMed ID: 25415267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsecretory multiple myeloma in two dogs.
    MacEwen EG; Patnaik AK; Hurvitz AI; Bradley R; Claypoole TF; Withrow SJ; Erlandson RA; Lieberman PH
    J Am Vet Med Assoc; 1984 May; 184(10):1283-6. PubMed ID: 6735847
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clear cell myeloma: report of a case].
    Xu H; Li J; Yang S
    Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):196-7. PubMed ID: 24842022
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary ALK-negative anaplastic large cell lymphoma with extensive bone involvement mimicking multiple myeloma and metastatic carcinoma.
    Souto Filho JTD; de Morais RA; Silveira ALO; Lacerda AP; Pires AZ; Ribeiro HAA; Fassbender IPB; Ribeiro JMMC; Figueiredo LCS; de Sales LR; Ferreira Júnior WDS; Dias YP
    Int J Hematol; 2019 Jul; 110(1):1-2. PubMed ID: 31093934
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients.
    Giuliani N; Lisignoli G; Novara F; Storti P; Zaffaroni N; Villa R; Sammarelli G; Agnelli L; Todoerti K; Bernardo ME; Manferdini C; Colla S; Abeltino M; Bolzoni M; Rocci A; Gabusi E; Palumbo A; Zuffardi O; Neri A; Rizzoli V
    Leukemia; 2010 Jul; 24(7):1368-70. PubMed ID: 20485369
    [No Abstract]   [Full Text] [Related]  

  • 16. Amyloidoma of the clavicle.
    Rachbauer F; Kreczy A; Bodner G
    AJR Am J Roentgenol; 2003 Sep; 181(3):771-3. PubMed ID: 12933479
    [No Abstract]   [Full Text] [Related]  

  • 17. [Extramedullary plasmacytoma].
    Sucker C; Stockschläder M
    Dtsch Med Wochenschr; 2002 Jan; 127(4):153-5. PubMed ID: 11807659
    [No Abstract]   [Full Text] [Related]  

  • 18. The Role of Imaging in the Treatment of Patients With Multiple Myeloma in 2016.
    Terpos E; Dimopoulos MA; Moulopoulos LA
    Am Soc Clin Oncol Educ Book; 2016; 35():e407-17. PubMed ID: 27249748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo.
    Lwin ST; Fowler JA; Drake MT; Edwards JR; Lynch CC; Edwards CM
    Mol Cancer; 2017 Feb; 16(1):49. PubMed ID: 28241871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth of a plasma cell myeloma in lathyritic mice.
    Martino LJ; Yeager VL; Taylor JJ
    Arch Pathol; 1975 Oct; 99(10):536-9. PubMed ID: 1191122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.